Emmanuel Zachariah Ph.D.

Founder/ Chief Executive Officer & Chief Scientific Officer

Dr. Zachariah began his postdoctoral training in Microarrays and Microfluidics fields at The National
University of Singapore and has voluminous background in Microarrays, Microfluidics, Biosensors,
Immunodiagnostics, Cancer research and personalized medicine. Creatively integrating technologies
from diverse fields and transforming these elements into world class product solutions is his specialty.
For the past 5 years he has developed several Focused microarrays for pathway analyses. Recent
accomplishments include innovations for the Neutraceutical screening method for WellGen. Dr.
Zachariah also was a founding member of Biosensor Focused Interest Group, Singapore in 2001, and
pioneered the application of microfluidic devices for the biological applications such as Polymerase
chain reaction (PCR), DNA extraction, micro Capillary Electrophoretic (CE) separation and Lab on
Chip. Earlier research and development on the Biosensors at National University of Singapore resulted
in development of various Biosensors. He established first microarray facility at the National University
of Singapore during 1998. Three United States Patents have been issued to Dr. Zachariah to date.
Another two patent applications on personalized cancer medicine is currently being prosecuted in the
United States.

Harun Sevimli, MBA

Director, International Business Development

Mr. Sevimli has extensive experience in international trade, consulting, financing, and marketing. He is
multi national and multi lingual. He has owned companies in Germany, Turkey and in the U.S. and
handled logistics for WFP/U.N. for the Food Bank in Northern Iraq. His latest company, Amerturk, Inc, a
full service asset management partner for electronics retailers and wholesalers includes several Fortune
500 companies for customers. Mr. Sevimli brings his skills in international trade to the Consumer Genetics
product line. He has helped to established partners in more than 33 countries since the end of 2008. Mr.
Sevimli has a degree in finance.